Quantcast
Last updated on April 17, 2014 at 15:37 EDT

Latest Insulin Stories

2013-09-17 08:31:18

Company to showcase late-stage pipeline, including efficacy, safety and patient-reported health outcomes data for investigational GLP-1 receptor agonist INDIANAPOLIS, Sept. 17, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that a total of 31 abstracts will be presented at the 49(th) European Association for the Study of Diabetes Annual Meeting in Barcelona, September 23-27. In seven presentations, Lilly will share Phase III data for dulaglutide, its investigational...

2013-09-16 12:27:44

MONTREAL, Sept. 16, 2013 /PRNewswire-iReach/ -- Major marketing and distribution firm montméd will make DiaClin skin care products, designed for general and diabetes use, available for Canadian consumers (Photo: http://photos.prnewswire.com/prnh/20130916/MN80061) International medical supply distributor and manufacturing firm montméd Inc. today announced that it will soon launch the DiaClin line of general and diabetes skin care products in the Canadian consumer marketplace. DiaClin offers...

Cancer Drug To Treat Diabetes
2013-09-16 12:07:11

Brett Smith for redOrbit.com - Your Universe Online New research from a team of American scientists has identified both a biochemical pathway involved in the development of diabetes and a drug already approved by the FDA for the treatment of cancer that is capable of regulating that pathway. Findings from the research were published as two separate online articles in Nature Medicine on Sunday. After a meal, blood glucose levels increase and insulin causes cells in the liver to store...

2013-09-13 12:26:07

Clinicians, Patients and Device Manufacturers Discuss Options for Verifying the Performance of Meters and Strips Post FDA-Clearance FOSTER CITY, Calif., Sept. 13, 2013 /PRNewswire-USNewswire/ -- Diabetes experts met this week in Bethesda, Md., to identify new measures to ensure the safety of patients using potentially inaccurate self-monitoring blood glucose (SMBG) systems. This meeting comes on the heels of recent evidence demonstrating that some monitors fail to consistently meet accuracy...

2013-09-10 08:31:20

TAIPEI, Sept. 10, 2013 /PRNewswire/ -- TWi Biotechnology, Inc., today announced that it has received an official notification of patent allowance for AC-201, TWi Biotechnology's lead drug candidate, from the United States Patent & Trademark Office. The granted patent, US patent number 8,536,152, covers AC-201's use as a combination therapy with other existing blood glucose lowering therapy agents to treat Type II diabetes. The patent is part of TWi Biotechnology's broad...

2013-09-09 08:27:53

-- Funding Will Support Broad Scale Commercialization of CeQur PaQ® Insulin Delivery Device- HORW, Switzerland, Sept. 9, 2013 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the closing of a $27 million dollar Series B financing. The financing was led by two new private investors with the participation of all current shareholders, and will support manufacturing scale up for the CeQur PaQ(®) simple...

2013-09-09 08:26:20

Study suggests novel insulin sensitizer may prevent cognitive decline in people with Alzheimer's-related dementia KALAMAZOO, Mich., Sept. 9, 2013 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) has announced that Jerry Colca, PhD, co-founder and chief scientific officer of MSDC, will present results of a Phase 2a study on September 9 at the 14th International Conference on Alzheimer's Drug Discovery. In people with dementia due to Alzheimer's disease (AD) who...

2013-09-06 12:21:58

BOSTON, Sept. 6, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest Type 1 Diabetes (T1DM) competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: -- Save the cells: immune therapies for T1DM -- Beta-cell regeneration strategies -- Pancreatic replacement via...

2013-09-04 08:26:08

Research has shown that giving obese rodents a recently identified circulating protein called fibroblast growth factor 21 (FGF21) helps improve their metabolism. Now investigators reporting in the Cell Press journal Cell Metabolism reveal that a variant of FGF21 has similar effects in obese people with type 2 diabetes. "Our findings suggest that FGF21 has the ability to favorably affect body weight and to partially normalize abnormal lipid levels in patients with diabetes. These are...

2013-09-04 08:01:27

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that among obese people who had lost considerable weight, those with high insulin levels–a marker of insulin resistance in the body–were the most likely to experience better blood vessel function following the weight loss. These findings appear online in the Journal of the American College of Cardiology. Obesity has emerged as one of the most critical health care problems in the U.S....


Latest Insulin Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (2 articles) »